Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha for viral hepatitis

M M Jonas1

  • 1Combined Program in Gastroenterology, Children's Hospital, Boston, Massachusetts, USA.

Journal of Pediatric Gastroenterology and Nutrition
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multivisceral transplantation using a 2.9 kg neonatal donor.

Pediatric transplantation·2012
Same author

Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.

Journal of viral hepatitis·2012
Same author

Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.

Journal of viral hepatitis·2007
Same author

Non-invasive cardiac output monitoring.

Intensive & critical care nursing·2004
Same author

A comparison of lithium dilution cardiac output measurements made using central and antecubital venous injection of lithium chloride.

Journal of clinical monitoring and computing·2003
Same author

Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.

Clinical immunology (Orlando, Fla.)·2001
Same journal

Foreign body ingestions in children and adolescents: A position paper of the ESPGHAN endoscopy special interest group.

Journal of pediatric gastroenterology and nutrition·2026
Same journal

Abdominal pain in pediatric immunoglobulin A vasculitis: Risk factors and severity predictors in a multicenter cohort.

Journal of pediatric gastroenterology and nutrition·2026
Same journal

Cognitive assessment in children with intestinal failure on and weaned off parenteral nutrition.

Journal of pediatric gastroenterology and nutrition·2026
Same journal

Safety of infant milks: Contamination with cereulide. A commentary by ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology, and Nutrition).

Journal of pediatric gastroenterology and nutrition·2026
Same journal

ESPGHAN position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver disease.

Journal of pediatric gastroenterology and nutrition·2026
Same journal

Treatment outcomes and determinants of refractory peptic ulcer disease in children: A prospective study from Vietnam.

Journal of pediatric gastroenterology and nutrition·2026
See all related articles

Interferon-alpha (IFN-alpha) shows promise for treating chronic viral hepatitis in children. Further research is needed to confirm safety and efficacy in pediatric populations.

Area of Science:

  • Hepatology
  • Virology
  • Pediatric Gastroenterology

Background:

  • Interferon-alpha (IFN-alpha) is a potential treatment for chronic viral hepatitis.
  • Efficacy of IFN-alpha is demonstrated, though not universal.
  • Pediatric patients are underrepresented in chronic viral hepatitis studies.

Purpose of the Study:

  • To evaluate the potential of IFN-alpha for treating chronic viral hepatitis in children.
  • To highlight the need for pediatric-specific safety and efficacy data.

Main Methods:

  • Review of existing data on IFN-alpha treatment for chronic viral hepatitis.
  • Analysis of pediatric patient populations and their infection timelines.
  • Assessment of reported pediatric tolerance to IFN-alpha therapy.

Related Experiment Videos

Main Results:

  • Children are often more recently infected with viral hepatitis.
  • Longer life expectancies in children may lead to increased long-term morbidity.
  • Children appear to tolerate IFN-alpha therapy well.

Conclusions:

  • Treatment of chronic viral hepatitis in children with IFN-alpha should be strongly considered.
  • Pediatric-specific protocols are necessary to determine safety and efficacy.
  • Further investigation into pediatric treatment is warranted.